Nicholas Vogelzang, MD on Phase 2 TRITON2 Clinical Trial @CCCNevada

Nicholas Vogelzang, MD on Phase 2 TRITON2 Clinical Trial @CCCNevada

Cancer-News

4 weeks
20 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 1
Category:
Description:
Nicholas Vogelzang, MD of Comprehensive Cancer Center @CCCNevada discusses the single arm, phase 2, TRITON2 clinical trial supported FDA approval of Rubraca in mCRPC
Up Next Autoplay